PARP7和酸受体不同调节乳腺癌细胞增殖和STING诱导的I型干扰素信号传递
Ninni E Olafsen1, Samaneh S Åhrling1, Marit Rasmussen1
1Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
Cellular oncology (Dordrecht, Netherlands)
|December 23, 2025
概括
通过RBN2397抑制PARP7,通过调节酸受体 (AHR) 和I型干扰素 (IFN-I) 信号,影响癌细胞增殖. 激活STING可能会增强某些癌症细胞系的RBN2397敏感性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 聚 ((ADP-ribose) 聚合酶7 (PARP7) 对I型干扰素 (IFN-I) 和基受体 (AHR) 信号通路进行负调节.
- PARP7 在细胞增殖和抗瘤免疫力中起作用.
- 在几个癌细胞系中观察到RBN2397抑制PARP7的抗增殖效应,但AHR和IFN-I信号传递的作用尚未完全理解.
研究的目的:
- 研究RBN2397对AHR和IFN-I信号传递在小鼠乳腺癌细胞中的影响.
- 确定AHR和IFN-I信号在抑制PARP7的抗增殖作用中的作用.
- 为了探索RBN2397的抗增殖作用的细胞系特异性.
主要方法:
- 用AHR配体RBN2397和干扰素基因刺激剂 (STING) 激动剂DMXAA.治疗小鼠乳腺癌细胞.
- 该研究评估了这些治疗对AHR和IFN-I信号通路的影响.
- 细胞增殖被测量以评估治疗的抗增殖作用.
主要成果:
- RBN2397治疗增强了AHR连接体信号传递和STING诱导的IFN-I反应.
- 只有Py8119细胞对RBN2397的抗增殖作用表现出敏感性,与FOS相关抗原1 (FOSL1) 表达相关.
- 与DMXAA和RBN2397的联合治疗减少了抗性Py230细胞的增殖,这种效果通过AHR抑制进一步增强.
结论:
- 在调节癌细胞增殖方面,PARP7,AHR和STING诱导的IFN信号之间的相互作用是复杂的.
- 激活STING可能会增强某些癌细胞系对RBN2397.7抗增殖作用的敏感性.
- 在RBN2397介导的生长抑制中FOSL1的作用是细胞系特异性的.
相关概念视频
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
The JAK-STAT Signaling Pathway
11.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.7K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K


